Tocilizumab for refractory uveitis associated with juvenile idiopathic arthritis: A report of two cases

Abstract

To our knowledge, these are the first reports of successful methotrexate withdrawal during tocilizumab treatment of JIA-associated uveitis. The administration of tocilizumab without methotrexate could be considered in patients with JIA-associated uveitis unresponsive to conventional therapy.